Cardio beat weights for metabolic gains when paired with dieting

Cutting calories is the standard route to weight loss, but weight is not the only thing at stake: blood sugar control, blood fats and blood pressure are the markers that shape long-term metabolic risk. Individual studies testing whether exercise adds anything to a low-calorie diet on those markers have produced inconsistent results. It also matters which kind of exercise earns its place, since time and effort are limited. This review pooled the trial evidence to ask whether exercise plus diet beats diet alone, and whether aerobic work, resistance work or the combination drives any advantage.

The authors searched four major databases from their inception to August 2024 for randomised trials comparing exercise plus a low-calorie diet against the diet alone in adults with overweight and obesity. Six reviewers independently screened studies, extracted data and assessed quality, all in duplicate. Ninety-seven eligible trials were included. Outcomes covered glucose control, insulin, insulin resistance, blood lipids and blood pressure, and results were combined using standard pooling methods.

Adding exercise to a weight-loss diet significantly improved serum glucose, insulin, insulin resistance, triglycerides, HDL cholesterol and both systolic and diastolic blood pressure compared with diet alone. The benefits were primarily associated with aerobic exercise rather than resistance training or combined programmes. Most improvements in cardiovascular risk factors appeared in supervised, high-intensity programmes, with cycling standing out. The combination of aerobic exercise and a weight-loss diet looked especially effective in metabolically healthy obese individuals. The authors grade the overall certainty of the evidence as moderate to low.

This is a useful tidy-up of a messy literature, resolving inconsistent single trials into a fairly consistent overall picture. It also complicates a popular assumption: that lifting weights during a diet does the same job for metabolic markers as cardio. Here the cardiometabolic benefits tracked with aerobic work, not resistance training, though resistance training was not tested for its other established benefits. Open questions remain about unsupervised, real-world exercise, about why cycling in particular stood out, and about how firm these conclusions are given the moderate to low certainty of the evidence.

If you are eating in a deficit and care about blood sugar, blood fats and blood pressure rather than the scale alone, this is a reason to think aerobic exercise adds something the diet by itself does not. The pattern favoured supervised, high-intensity aerobic sessions, which suggests structure and effort both mattered in these trials. It is not a verdict against resistance training, which was simply less tied to these particular markers here. As ever with pooled trial evidence of moderate to low certainty, the direction is more trustworthy than the exact size of the effect.